http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015106129-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7aa001f3235c07b0298867908d45e21 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
filingDate | 2015-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a153279f494521614591dcef05d6af59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c92a8a833043cf5f555eafd1b11263ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8772874bb2955810280be5e2f50137c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47712aaab798f8850d0ee61c44afb9d8 |
publicationDate | 2015-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2015106129-A1 |
titleOfInvention | Diagnosis of chronic liver diseases |
abstract | A method of diagnosing a liver disease comprises the steps of: a) obtaining a biological sample from a human or animal subject, b) determining one or more biomarkers that are associated with said liver disease, c) measuring the level of said one or more biomarkers in said biological sample, d) comparing said level of said one or more biomarkers to a control level of said one or more biomarkers, and e) providing a treatment for said liver disease in said human or animal subject to a differing level of at least one of said one or more biomarkers has been detected based on analyzing the above steps, wherein said biomarker is a protein or a peptide fragment thereof selected from the group consisting of: Kininogen-1, Nesprin-1, Vitronectin, Nieman-Pick C1 -like protein 1, Protocadherin Fat 4, Probable E3 ubiquitin- protein ligase HERC2, Extracellular matrix protein FRAS1, E3 ubiquitin-protein ligase UBR3, WD repeat-containing protein 90, Ephrin type-B receptor 3, Probable E3 ubiquitin-protein ligase MYCBP2, Transient receptor potential cation channel subfamily M member 4, Protein FAM71 B, WD repeat-containing protein 85, E3 ubiquitin-protein ligase UBR2, Transmembrane protein 206, Mucin-6, Myotubularin-related protein 9, Nick-associated protein 1, vesicular glutamate transporter 2, Arf-GAP with GTPase, ANK repeat and PH domain containing protein 3, Slit homolog 2 protein, Beta-1,3-galactosyl-0-glycosyl- glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase 7, Fibronectin type III domain containing protein 3C1, and Homeobox even-skipped homolog protein 1, a nucleic acid encoding said protein, or a microRNA specifically regulating the expression of said protein at an RNA level. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10601547-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11677502-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11108501-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017210147-A1 |
priorityDate | 2014-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 491.